← Back to headlines





Breakthrough reported in personalized cancer vaccines
Merck and Moderna announced that a personalized cancer vaccine showed promise in preventing the return and spread of melanoma in a large trial involving over 1,000 patients, offering new hope for cancer patients.
23 Aug, 13:28 — 23 Aug, 13:28
Related Stories

Busy Philipps Reveals Rare Brain Tumor Diagnosis and Recovery
45m ago

FDA Approves New Pancreatic Cancer Drug Following Breakthrough Clinical Trials
1h ago

WHO Declares End of Ebola Outbreak in Uganda Amid Rising Cases in Congo
4h ago

Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality
5h ago